Michael Wolff
Urology · Burlington, NCNPI 1902975428
Payments from drug & device makers
Across 256 payments — averaging $19.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Endo Pharmaceuticals Inc.$627
- Antares Pharma, Inc.$528
- Neotract Inc.$411
- C. R. Bard, Inc. & Subsidiaries$356
- Myovant Sciences Inc.$248
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,53092%
- Education$3698%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 38 | $1,058 |
| Endo Pharmaceuticals Inc. | 39 | $627 |
| Antares Pharma, Inc. | 37 | $528 |
| Neotract Inc. | 7 | $411 |
| C. R. Bard, Inc. & Subsidiaries | 16 | $356 |
| Myovant Sciences Inc. | 14 | $248 |
| Zyla Life Sciences, Inc. | 25 | $226 |
| Clarus Therapeutics Inc. | 13 | $191 |
| Pfizer | 10 | $191 |
| Sumitomo Pharma America, Inc. | 9 | $170 |
| Bayer | 7 | $153 |
| Hollister Incorporated | 4 | $85 |
| Agiliti Surgical, Inc. | 2 | $80 |
| Acerus Pharmaceuticals Corporation | 5 | $79 |
| Mission Pharmacal Company | 4 | $70 |
| Halozyme Inc | 3 | $52 |
| Urovant Sciences Inc | 3 | $50 |
| AbbVie | 3 | $43 |
| Boston Scientific | 3 | $42 |
| Teleflex LLC | 2 | $34 |
| Tolmar Pharmaceuticals, Inc. | 1 | $29 |
| Tolmar, Inc. | 1 | $27 |
| Medtronic(2 entities) | 2 | $25 |
| Dendreon Pharmaceuticals LLC | 1 | $24 |
| Laborie Medical Technologies Corp. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Blue Earth Diagnostics | 1 | $16 |
| Novartis | 1 | $16 |
| Cure Medical LLC | 1 | $14 |
| Angiodynamics, Inc. | 1 | $12 |
| Astellas Pharma US Inc | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,898 in reported general payments places this provider in the 65th percentile of 434 urology providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 16 | $41,186 |
| GemtesaVibegron | 16 | $13,140 |
| MyrbetriqMirabegron | 17 | $12,829 |
| Tamsulosin Hcl | 177 | $1,867 |
| Dutasteride | 60 | $1,238 |
| Finasteride | 79 | $852 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 13 | $302 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Orgovyx, Gemtesa | $170 | $54,32632 claims |
| Astellas Pharma US IncMyrbetriq | $3 | $12,82917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 434 urology providers in North Carolina.
Other urology in Burlington
- Daniel GeorgeDurham$17.6M
- Robert LippittSmithfield$11.4M
- Thomas PolascikDurham$4.7M
- Judd MoulDurham$4.1M
- John WrennGreensboro$2.9M
- Michael KennellyCharlotte$1.4M
- John KasparRaleigh$1.1M
- Scott MacdiarmidGreensboro$882K
- Glenn PremingerDurham$736K
- Jonathan HamiltonGreenville$695K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.